Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

89.20p
   
  • Change Today:
      0.20p
  • 52 Week High: 99.35p
  • 52 Week Low: 47.52p
  • Currency: UK Pounds
  • Shares Issued: 967.06m
  • Volume: 68,973
  • Market Cap: £862.62m
  • Beta: 1.19

Latest Deals

Traded Action Notifier PriceAmountValue
15-Oct-25 Sell Ije Nwokori 89.67p 298,675 £267,821.88
15-Oct-25 Transfer From Ije Nwokori 0.000p 633,249 £0.00
13-Oct-25 Transfer From Giles Wilson 0.000p 167 £0.00
13-Oct-25 Buy Giles Wilson 89.50p 167 £149.46
13-Oct-25 Transfer From Ije Nwokori 0.000p 167 £0.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
15-Oct-25 Sell Ije Nwokori 89.67p 298,675 £267,821.88
13-Oct-25 Buy Ije Nwokori 89.50p 167 £149.46
13-Oct-25 Buy Giles Wilson 89.50p 167 £149.46
15-Oct-25 Transfer From Ije Nwokori 0.000p 633,249 £0.00
13-Oct-25 Transfer From Ije Nwokori 0.000p 167 £0.00

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £7,024,500
Ije Nwokori 341,937 £305,008
Giles Wilson 231,142 £206,179
Robyn Perriss 94,328 £84,141
Andrew Harrison 76,594 £68,322
Lynne Weedall 40,054 £35,728
Ian Rogers 20,270 £18,081

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £329,988,656
IngreGrsy Limited 369,942,440 £329,988,656
Permira Holdings Limited 364,142,440 £324,815,056
Artemis Investment Management LLP 106,282,806 £94,804,263
Fidelity Management & Research 32,500,000 £28,990,000
Intertrust Employee Benefit Trustee Limited 135,000 £120,420

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 89.20p
Change Today 0.20p
% Change 0.22 %
52 Week High 99.35p
52 Week Low 47.52p
Volume 68,973
Shares Issued 967.06m
Market Cap £862.62m
Beta 1.19

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 06-Nov-2025

Time Volume / Share Price
12:02 139 @ 89.20p
12:02 5 @ 89.20p
11:47 86 @ 88.95p
11:38 4 @ 88.80p
11:33 225 @ 88.93p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page